Insider Trading History of Deerfield Private Design International, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Deerfield Private Design International, L.p. since 2008. The trader's CIK number is 1407589. At the time of the last reporting, Deerfield Private Design International, L.p. was the 10% Owner of Ista Pharmaceuticals Inc. (stock ticker symbol ISTA). Also see all insider trading activities at Ista Pharmaceuticals Inc.

Note that in the past Deerfield Private Design International, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ista Pharmaceuticals Inc (ISTA) by Deerfield Private Design International, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 ISTA 0 $0 1,713,056 $18,055,109 0 $0

Yearly summary of insider trading at Dynavax Technologies Corp (DVAX) by Deerfield Private Design International, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 DVAX 0 $0 4,851,538 $1,188,626 0 $0


Insider trading activities at 2 companies by Deerfield Private Design International, L.p.:

1. Ista Pharmaceuticals Inc (ISTA)

2. Dynavax Technologies Corp (DVAX)

Table 1. Insider trading of Ista Pharmaceuticals Inc (ISTA) by Deerfield Private Design International, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-05-04 ISTA Sale 1,316,948 10.53 13,867,462
2011-05-06 ISTA Sale 285,141 10.60 3,022,494
2011-05-05 ISTA Sale 110,967 10.50 1,165,153

Table 2. Insider trading of Dynavax Technologies Corp (DVAX) by Deerfield Private Design International, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-10-22 DVAX Sale 4,851,538 .24 1,188,626

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deerfield Private Design International, L.p. (10% Owner of Ista Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.